Colorectal cancer (CRC) is among the leading causes of cancer-related deaths globally. While surgical resection remains the primary treatment, the inaccurate identification of tumor margins and the presence of undetectable occult metastases pose significant clinical challenges. Near-infrared (NIR) fluorescence guided surgery (FGS) presents a potential solution to these issues; however, currently available clinical probes suffer from insufficient targeting specificity and limited overall imaging performance. This study introduces a novel NIR fluorescent probe, E-PEG4-S0456, designed to target fibroblast growth factor receptor (FGFR) for precise imaging of CRC. This probe demonstrates excellent photophysical properties and a strong binding affinity to FGFR, allowing for long-term, high-contrast imaging of both primary and metastatic CRC lesions across various animal models, achieving high tumor-to-background ratios and favorable biosafety profiles. Given these advantages, E-PEG4-S0456 has been validated as a promising tool with the potential to advance NIR−FGS technology and enhance the precision of diagnosis and treatment for CRC.
No takes yet. Share an insight, caveat, or question.
Chai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: